1 of 1
Story summary
- Researchers at Oregon Health & Science University reported that a three-therapy regimen given to newborn primates within three days cleared HIV infection.
- The regimen combined neutralizing antibodies, standard antiretroviral therapy, and the CCR5-blocking monoclonal antibody leronlimab, was given within 72 hours, and achieved viral clearance, a result not seen with single therapy, according to coauthor Nancy Haigwood.
- The team plans to test the combination in recently exposed adults before newborn trials.
